|
December 11, 2025 MGB Cancer Grand Rounds 2025-2026: Thinking Outside the B(oT)ox for the Treatment of AL Amyloidosis and Other Plasma Cell Disorders |
12/11/2025 - 12:00pm to 1:00pm EST |
|
December 18, 2025 MGB Cancer Grand Rounds 2025-2026: Navigating the Changing Treatment Landscape in Locally Advanced Rectal Cancer |
12/18/2025 - 12:00pm to 1:00pm EST |
|
December 25, 2025 MGB Cancer Grand Rounds 2025-2026: No Session |
12/25/2025 - 12:00pm to 1:00pm EST |
|
January 8, 2026 MGB Cancer Grand Rounds 2025-2026: ASH Updates |
01/08/2026 - 12:00pm to 1:00pm EST |
|
January 15, 2026 MGB Cancer Grand Rounds 2025-2026: Connecting the Biggest to the Smallest: Building an Ambulatory First Strategy in an Academic Enterprise |
01/15/2026 - 12:00pm to 1:00pm EST |
|
January 22, 2026 MGB Cancer Grand Rounds 2025-2026: Translational Immuno-Oncology in Melanoma and Beyond |
01/22/2026 - 12:00pm to 1:00pm EST |
|
January 29, 2026 MGB Cancer Grand Rounds 2025-2026: Focused ultrasound Blood Brain Barrier opening in patients with GBM. |
01/29/2026 - 12:00pm to 1:00pm EST |
|
February 5, 2026 MGB Cancer Grand Rounds 2025-2026: • The Emerging Landscape of Antibody Drug Conjugate Resistance |
02/05/2026 - 12:00pm to 1:00pm EST |
|
February 12, 2026 MGB Cancer Grand Rounds 2025-2026: Direct Delivery of CAR T Cell Therapy to Triple Negative Breast Cancer |
02/12/2026 - 12:00pm to 1:00pm EST |
|
February 19, 2026 MGB Cancer Grand Rounds 2025-2026: Identifying and Understanding New Treatments Targeting IDH-mutant Gliomas |
02/19/2026 - 12:00pm to 1:00pm EST |